PFE – Muted expectations for PFE are likely driven by concerns about the firm’s ability to effectively offset competitive headwinds with substantial growth from new products
November 20, 2017
-
- Pfizer Inc. (PFE:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) Earnings, with a 15.7x Uniform P/E. These muted valuations appear driven by concerns about the firm’s ability to effectively offset competitive headwinds with substantial growth from new products
- Specifically, while the firm has a number of possible blockbuster drugs in its pipeline, markets are pricing in uncertainty surrounding their potential. Additionally, the firm is likely to continue to face LOE and competition-related headwinds going forward, making it increasingly difficult for them to drive material operational improvements